| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 195 | 207 | 287 | 361 |
| Cost of Material Consumed | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 |
| Gross Margins | 100 | 100 | 100 | 100 |
| Employee Benefit Expenses | 71 | 77 | 85 | 94 |
| Other Expenses | 66 | 83 | 100 | 112 |
| EBITDA | 58 | 47 | 102 | 155 |
| OPM | 29.74 | 22.71 | 35.54 | 42.94 |
| Other Income | 4 | 0 | 4.6 | 15 |
| Finance Cost | 18 | 26 | 31.5 | 25 |
| D&A | 43 | 49 | 52.5 | 62 |
| EBIT | 15 | -2 | 49.5 | 93 |
| EBIT Margins | 7.69 | -0.97 | 17.25 | 25.76 |
| PBT | -2 | -28 | 22.2 | 83 |
| PBT Margins | -1.03 | -13.53 | 7.74 | 22.99 |
| Tax | 0.5 | -5 | 8.6 | 27 |
| PAT | -2.5 | -23 | 13.6 | 56 |
| NPM | -1.28 | -11.11 | 4.74 | 15.51 |
| EPS | -0.27 | -2.48 | 1.46 | 5.6 |
Financial Ratios |
2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating Profit Margin | 29.74 | 22.71 | 35.54 | 42.94 |
| Net Profit Margin | -1.28 | -11.11 | 4.74 | 15.51 |
| Earning Per Share (Diluted) | -0.27 | -2.48 | 1.46 | 5.6 |
| Assets | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Fixed Assets | 204 | 197 | 317 | 286 |
| CWIP | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 |
| Trade Receivables | 64 | 57 | 118 | 143 |
| Inventory | 0 | 0 | 0 | 0 |
| Other Assets | 254 | 245 | 107.39 | 227 |
| Total Assets | 522 | 499 | 542.39 | 656 |
| Liabilities | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Share Capital | 9.1 | 9.28 | 9.289 | 10 |
| FV | 1 | 1 | 1 | 1 |
| Reserves | 206 | 201 | 245 | 408 |
| Borrowings | 133 | 165 | 105 | 62.6 |
| Trade Payables | 24 | 28 | 22 | 29 |
| Other Liabilities | 149.9 | 95.72 | 161 | 146.4 |
| Total Liabilities | 522 | 499 | 542.29 | 656 |
| Cash-Flow Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| PBT | -2 | -28 | 25 | 83 |
| OPBWC | 64 | 50 | 107 | 167 |
| Change in Receivables | -24 | 5 | -40 | -34 |
| Change in Inventories | 0 | 1 | 0 | 0 |
| Change in Payables | -0.4 | 0 | -3.6 | 6 |
| Other Changes | -14 | 6 | 10 | -14 |
| Working Capital Change | -38.4 | 12 | -33.6 | -42 |
| Cash Generated From Operations | 25.6 | 62 | 73.4 | 125 |
| Tax | -9 | -7 | 5.8 | -4 |
| Cash Flow From Operations | 16.6 | 55 | 79.2 | 121 |
| Purchase of PPE | -60 | -36 | -23 | -113 |
| Sale of PPE | 0 | 0 | 0 | 0.1 |
| Cash Flow From Investment | -69 | -54 | -26.9 | -109 |
| Borrowing | 33 | -16 | -19.8 | -44 |
| Dividend | 0 | 0 | 0 | 0 |
| Equity | 0 | -1 | 0 | 137 |
| Others From Financing | 40.5 | -2 | -47 | -44 |
| Cash Flow from Financing | 73.5 | -19 | -66.8 | 49 |
| Net Cash Generated | 21.1 | -18 | -14.5 | 61 |
| Cash at the Start | 14 | 35 | 15.772 | -2 |
| Cash at the End | 35.1 | 17 | 1.27 | 59 |
| Name | Designation | Experience | Linkedin Profile |
|---|---|---|---|
| Piyush Somani | CMD & CEO | 20 Yrs |
|
| Komal Somani | Director & CMO | 11 Yrs |
|
| Nadukuru Sita Ramaiah | CFO | 17 Yrs |
|